Cefuroxime Treatment Research Articles

Liver function during treatment with cefuroxime.

The liver function was studied in 15 patients before and during treatment with cefuroxime. Four elderly patients had a prolonged half-life of galactose at admission but they all showed declining values during the cefuroxime treatment. Only in one patient did the galactose half-life increase during treatment (from 14 to 25 min.). This patient was an old diabetic who also had prostatic cancer. Cefuroxime treatment seems to be well tolerated also in patients with signs of impaired metabolic liver function at start of treatment.

Cefuroxime treatment of urethritis caused by a beta-lactamase-producing strain of Neisseria gonorrhoeae

A patient who contracted urethritis from a beta-lactamase-producing strain of Neisseria gonorrhoeae was successfully treated with the cephalosporin derivative cefuroxime. As expected, neither cefuroxime nor cefamandole was hydrolysed by plasmid-coded gonococcal beta-lactamase. Cefuroxime ought to be a valuable and efficacious substitute for penicillins in the treatment of gonhorrhoea due to beta-lactamase-producing gonococcal strains.

Renal function during cefuroxime treatment in patients with pre-existing renal impairment.

Renal function during cefuroxime treatment in patients with pre-existing renal impairment.

Cefuroxime Treatment of Patients with Lower Respiratory and Urinary Tract Infections

Cefuroxime Treatment of Patients with Lower Respiratory and Urinary Tract Infections